Literature DB >> 4047600

The effect of long-term near normal glycemic control on mild diabetic retinopathy.

T R Friberg, J Rosenstock, G Sanborn, A Vaghefi, P Raskin.   

Abstract

Thirty-three type l diabetics who used continuous subcutaneous infusion of insulin (CSll) and 24 diabetics on conventional treatment (maximum of two injections per day) were studied prospectively with ophthalmologic examinations, fundus photography, fluorescein angiography, and glycosylated hemoglobin (HbA1) determinations. Both groups were similar with respect to age, duration of diabetes, and length of follow-up. At entry almost all patients had only mild forms of diabetic retinopathy although three CSll patients had early proliferative retinopathy. The CSll groups achieved superior glycemic control throughout the study (mean HbA1 = 7.4% vs. 10.2%). After an average follow-up of more than 30 months, the CSll group showed significantly less progression of diabetic retinopathy as measured by macular aneurysm counts and by modified ETDRS grading. Careful control of glycemia may delay the progression of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4047600     DOI: 10.1016/s0161-6420(85)33903-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Visual improvement after long-term success of pancreatic transplantation.

Authors:  T R Friberg; A G Tzakis; P B Carroll; T E Starzl
Journal:  Am J Ophthalmol       Date:  1990-11-15       Impact factor: 5.258

2.  Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Jensen; T Lauritzen; T Deckert
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

Review 3.  Diabetic control and microvascular complications: the near-normoglycaemic experience.

Authors:  K F Hanssen; K Dahl-Jørgensen; T Lauritzen; B Feldt-Rasmussen; O Brinchmann-Hansen; T Deckert
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

4.  Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study.

Authors:  O Brinchmann-Hansen; K Dahl-Jørgensen; L Sandvik; K F Hanssen
Journal:  BMJ       Date:  1992-01-04

Review 5.  Results of the DCCT trial. Implications for managing our patients with diabetes.

Authors:  G Worrall
Journal:  Can Fam Physician       Date:  1994-11       Impact factor: 3.275

Review 6.  Current management of diabetic retinopathy.

Authors:  E Ai
Journal:  West J Med       Date:  1992-07

Review 7.  Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis.

Authors:  Alexa Klettner
Journal:  Mar Drugs       Date:  2016-02-03       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.